Condition
Neuronal Ceroid Lipofuscinosis CLN5
Total Trials
2
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
Treatment Research
1 treatments under study, led by Ngn101
Related Conditions
Often studied with 9 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Phase 1/2 (1)
Trial Status
Recruiting1
Active Not Recruiting1
Clinical Trials (2)
Research Network
Common Treatments
- Ngn1011
Active Sponsors
- Neurogene Inc.1
- University of Rochester1
Top Investigators
Neurogene Inc.
University of Rochester
Related Conditions
- Neuronal Ceroid Lipofuscinosis Cln71
- Neuronal Ceroid Lipofuscinosis Cln61
- Neuronal Ceroid Lipofuscinosis Cln81
- Batten Disease1
- Neuronal Ceroid Lipofuscinosis Cln31